Upregulated circZMIZ1 promotes the proliferation of prostate cancer cells and is a valuable marker in plasma.

In conclusion, these results revealed that circZMIZ1 might serve as a novel biomarker and a treatment target for prostate cancer treatment.
PMID: 31686520 [PubMed - as supplied by publisher]

Source: Neoplasma - November 3, 2019 Category: Cancer & Oncology Authors: Jiang H, Lv DJ, Song XL, Wang C, Yu YZ, Zhao SC Tags: Neoplasma Source Type: research